SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

34 hedge funds and large institutions have $77.1M invested in Sinovac Biotech, Ltd in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$128K
Puts
$3K
Net Calls
Net Calls Change

Top Buyers

1
+$1.81M
2
+$1.18M
3
+$333K
4
PAM
Panagora Asset Management
Massachusetts
+$261K
5
OTC
Opera Trading Capital
France
+$230K

Top Sellers

1
-$6.24M
2
-$206K
3
-$151K
4
FIM
Freedom Investment Management
Connecticut
-$141K
5
Morgan Stanley
Morgan Stanley
New York
-$128K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$63K
27
$32K
28
$25K
29
$19K
30
$9K
31
$5K
32
$3K
33
$3K
34
$147
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
1
2